AmSurg, SCA Stock Sales, Symbion Case Growth & More – 5 Recent Key Notes on ASC Companies
AmSurg CEO Christopher Holden sold 3,000 shares at an average price of $46.39 each for total transaction value of $139,170, according to a WKRB report.
Joseph T. Clark, chief development officer and executive vice president of Surgical Care Affiliates, sold 20,000 company shares at an average price of $28.38 each for a transaction total of $567,600, according to a WKRB report.
Nueterra Global Alliance has partnered with the Surgery Center of Pinehurst. The ASC is one of the first in its area to develop transparent pricing options.
Symbion facilities performed 51,970 cases during the first quarter of 2014, up from 51,906 in the same period in 2013. Revenue per case grew 4.3 percent from $2,602 to $2,713.
United Surgical Partners International reported $61 million in cash flow from operating activities in the first quarter of 2014, up from $38.6 million in the first quarter of 2013.
If you have a question, issue or note to suggest on an ASC management and development company please contact Carrie Pallardy at firstname.lastname@example.org or Laura Miller at email@example.com.
More Articles on ASC Issues:
What Are ASC Success Indicators for the Future?
Trending ASC Market Activity in 2014: 9 Articles
3 ASCs With Robotic Orthopedics Technology
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- CDC pleads Congress to approve Zika funding quickly — 6 observations
- Will the bronze plan disappear soon? 4 takeaways
- WHO reports nearly 600 healthcare attacks in 19 countries — 6 things to know
- Is the VA lacking resources or funding less critical areas? 6 insights
- Dr. Kenneth Chang performs 1st TIF procedure using new EsophyX Z device: 6 things to know